Literature DB >> 7211990

Vogt-Koyanagi-Harada syndrome with focal neurologic signs.

J R Lubin, J I Loewenstein, A R Frederick.   

Abstract

The Vogt-Koyanagi-Harada syndrome includes inflammation of the uveal tract, retina, and meninges. Integumentary and auditory signs are common. Neurologic involvement has been reported. We studied two patients who manifested many of the varied clinical signs of Vogt-Koyanagi-Harada syndrome, but who also showed focal neurologic involvement, including acute transverse myelitis and ciliary ganglionitis. Both patients responded well to corticosteroid therapy. The findings in these patients and the results of previous studies suggest that Vogt-Koyanagi-Harada syndrome is a cell-mediated autoimmune disorder in which a component of myelin acts as an inciting antigen.

Entities:  

Mesh:

Year:  1981        PMID: 7211990     DOI: 10.1016/0002-9394(81)90286-5

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  5 in total

1.  Vogt-Koyanagi-Harada syndrome: clinical and instrumental contribution.

Authors:  F Trebini; A Appiotti; R Bacci; D Daniele; A Inglezis; G Scarzella
Journal:  Ital J Neurol Sci       Date:  1991-10

2.  Vogt-Koyanagi-Harada syndrome, a rare association of Hodgkin's disease.

Authors:  S Y Chuah; A J Lyne; M W Dronfield
Journal:  Postgrad Med J       Date:  1991-05       Impact factor: 2.401

3.  A case of Vogt-Koyanagi-Harada syndrome in a patient affected by Hodgkin's disease.

Authors:  D Cipriani; G Landonio; C Canepari
Journal:  J Neurol       Date:  1989-07       Impact factor: 4.849

4.  Unusual neurologic manifestations of Vogt-Koyanagi-Harada disease: a systematic literature review.

Authors:  Moussa Toudou-Daouda; Abdoul Kadir Ibrahim-Mamadou
Journal:  BMC Neurol       Date:  2022-02-04       Impact factor: 2.474

Review 5.  Transverse myelitis.

Authors:  Shin C Beh; Benjamin M Greenberg; Teresa Frohman; Elliot M Frohman
Journal:  Neurol Clin       Date:  2013-02       Impact factor: 3.806

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.